Document Detail

Synergistic protection of PC12 cells from beta-amyloid toxicity by resveratrol and catechin.
MedLine Citation:
PMID:  14596889     Owner:  NLM     Status:  MEDLINE    
beta-Amyloid peptide (beta-AP) elicits a toxic effect on neurons in vitro and in vivo. Many environmental factors including antioxidants, metal ions and proteoglycans modify beta-AP toxicity. We have investigated on PC12 cells, the protective effect from beta-AP (1-41) of two plant polyphenols, resveratrol and catechin. PC12 cells treated with 10(-6)M beta-AP (1-41) for 16h decrease the cell viability at 24% of the control with an IC(50) value of 1.1+/-0.14 x 10(-8)M. Twenty-five micromolar resveratrol and 50 microM catechin protect PC12 cells from beta-AP (1-41) toxicity with the IC(50) value increased at 2.2+/-0.19 x 10(-7)M and at 8.9+/-0.7 x 10(-8)M, respectively. While the protective effect is concentration dependent for catechin, resveratrol shows a concentration-dependent biphasic effect. Up to 50 microM concentration, resveratrol protects PC12 cells from beta-AP (1-41) toxicity. At concentration higher than 50 microM, an inhibitory activity on cell proliferation appears. This antiproliferative effect is shown also in the absence of beta-AP (1-41). Resveratrol and catechin have a synergistic protective action. In the presence of 50 microM catechin and 10 microM resveratrol or 25 microM resveratrol and 10 microM catechin, the toxicity determined by 10(-7)M beta-AP (1-41) is almost completely abolished. Catechin is more effective than resveratrol in protecting PC12 cells from the toxicity of hydrogen peroxide. The protection from Oxygen Reactive Species (ROS) toxicity is concentration dependent for both resveratrol and catechin. In this case the protection is merely additive and the synergistic effect is not observed. These results demonstrate that resveratrol and catechin protect PC12 cells from beta-AP (1-41) toxicity and that their protective effect is synergistic. Such a protective effect probably is not due only to their antioxidant activity. The different chemical and biological activity shown by these compounds on several cell types and the complexity of the beta-AP (1-41) toxicity may explain the synergistic protective effect and suggest that the utilization of different compounds with synergistic activity may protect more effectively from complex mechanisms of toxicity.
Angela Conte; Silvia Pellegrini; Davide Tagliazucchi
Related Documents :
1730069 - In vitro studies on the regulation of endochondral ossification by vitamin d.
8930609 - Immunohistochemical demonstration of fsh and lh in the pituitary of the developing frog...
8327069 - Characterization of pro-opiomelanocortin processing in heterologous neuronal cells that...
1315599 - Morphodynamic response of the rat light pinealocytes to an injection act. implication o...
15931009 - Role of hensin in mediating the adaptation of the cortical collecting duct to metabolic...
1709959 - Co-existence of tyrosine hydroxylase and dopamine beta-hydroxylase immunoreactivity in ...
10861579 - Nucleolar size indicates the rapidity of cell proliferation in cancer tissues.
7814649 - Novel production of interleukin-1 receptor antagonist peptides in normal human cornea.
17097639 - Parkin is an e3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-i...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Brain research bulletin     Volume:  62     ISSN:  0361-9230     ISO Abbreviation:  Brain Res. Bull.     Publication Date:  2003 Nov 
Date Detail:
Created Date:  2003-11-04     Completed Date:  2004-01-09     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  7605818     Medline TA:  Brain Res Bull     Country:  United States    
Other Details:
Languages:  eng     Pagination:  29-38     Citation Subset:  IM    
Department of Agricultural Science, University of Modena e Reggio Emilia, via Kennedy 17, 42100, Reggio Emilia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amyloid beta-Peptides / antagonists & inhibitors,  toxicity*
Antioxidants / pharmacology*
Catechin / pharmacology*
Cell Count
Cell Death
Cell Survival / drug effects
Dose-Response Relationship, Drug
Drug Interactions
Lipid Peroxidation / drug effects,  physiology
PC12 Cells / drug effects*
Peptide Fragments / antagonists & inhibitors,  metabolism,  toxicity
Stilbenes / pharmacology*
Tetrazolium Salts / metabolism
Thiazoles / metabolism
Thiobarbiturates / metabolism
Reg. No./Substance:
0/Amyloid beta-Peptides; 0/Antioxidants; 0/Peptide Fragments; 0/Stilbenes; 0/Tetrazolium Salts; 0/Thiazoles; 0/Thiobarbiturates; 0/amyloid beta-protein (1-40); 154-23-4/Catechin; 298-93-1/thiazolyl blue; M1YZW5SS7C/thiobarbituric acid; Q369O8926L/resveratrol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The role of metals in neurodegenerative processes: aluminum, manganese, and zinc.
Next Document:  Hippocampal mGluR1 and consolidation of contextual fear conditioning.